Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › CD16A binding proteins and use for the treatment of immune disorders

CD16A binding proteins and use for the treatment of immune disorders

US Patent 7838635 · Granted Nov 23, 2010

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

N-containing heteroaryl derivative and pharmaceutical composition comprising sam2025
Organoids for drug screening and personalized medicine2025
Methods of generating highly-crystalline recombinant spider silk protein fibers2025
Bispecific molecules comprising an HIV-1 envelope targeting arm2024
CD3-binding molecules capable of binding to human and non-human CD32024
CD3-binding molecules capable of binding to human and non-human CD32024
HER2/neu-specific antibodies and methods of using same2024
HER2/neu-specific antibodies and methods of using same2024
HER2/neu-specific antibodies and methods of using same2024
Pyrazole compounds, pharmaceutical compositions thereof and use thereof2024
Bispecific binding molecules that are capable of binding CD137 and tumor antigen2024
Composite material, and methods for production thereof2024